Respiratory manifestations in amyloidosis

Chinese Medical Journal

Volumn 118, Issue 24, 2005, Pages 2027-2033

  Xu, Ling ^a   Cai, Bai Qiang ^a   Zhong, Xu ^a   Zhu, Yuan Jue ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Amyloidosis; Bronchus; Lung; Pleural effusion; Trachea

Indexed keywords

AMYLOID;

ADOLESCENT; ADULT; AMYLOIDOSIS; ARTICLE; BRONCHOSCOPY; BRONCHUS DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYOSURGERY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LARYNGOSCOPY; LARYNX DISORDER; LOW LEVEL LASER THERAPY; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG PARENCHYMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM DISEASE; PATHOLOGICAL ANATOMY; PHARYNX DISEASE; PLEURA BIOPSY; PLEURA EFFUSION; RESPIRATORY TRACT DISEASE; SENSITIVITY ANALYSIS; THORAX RADIOGRAPHY; TRACHEA DISEASE; TRACHEOSTOMY; AGED; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; BRONCHOSCOPY; FEMALE; HUMANS; LARYNGOSCOPY; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; RESPIRATORY TRACT DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644851054     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Buxbaum JN. The systemic amyloidoses. Curr Opin Rheumatol 2004;16:67-75.
2. Guidelines Working Group of UK Myeloma Forum, British Commitee for Standards in Haematology, British Society for Haematology. Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004;125:681-700.
3. Pasternak S, White VA, Gascoyne RD, et al. Monoclonal origin of localised orbital amyloidosis detected by molecular analysis. Br J Ophthalmol 1996;80:1013-1017.
4. Hamidi Asl K, Liepnieks JJ, Bihrle R, et al. Local synthesis of amyloid fibril precursor in AL amyloidosis of the urinary tract. Amyloid 1998;5:49-54.
5. Hagihara K, Nishikawa T, Isobe T, et al. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analysed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Bioph Res Co 2004;314:363-369.
6. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004;255:159-178.
7. Saitoh O, Kojima K, Teranishi T, et al. Renal amyloidosis as a late complication of Crohn's disease: a case report and review of the literature from Japan. World J Gastroenterol 2000;6:461-464.
8. Wester AL, Vatn MH, Fausa O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflamm Bowel Dis 2001; 7:295-300.
9. Jeong YJ, Lee KS, Chung MP, et al. Amyloidosis and lymphoproliferative disease in Sjogren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 2004;28:776-781.
10. Berk JL, O'Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Semin Respir Crit Care Med 2002;23:155-165.
11. Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax 1999;54:444-451.
12. O'Regan A, Fenlon HM, Beamis JF Jr, et al. Tracheobronchial amyloidosis: the Boston University experience from 1984 to 1999. Medicine 2000;79:69-79.
13. Gross BH. Radiographic manifestations of lymph node involvement in amyloidosis. Radiology 1981;138:11-14.
14. Liu YY, Lee YC, Chou TY, et al. Pulmonary alveolar-septal amyloidosis presenting as heart failure with unilateral pleural effusion: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1999;62:838-843.
15. Kurrus JA, Hayes JK, Hoidal JR, et al. Radiation therapy for tracheobronchial amyloidosis. Chest 1998; 114:1489-1492.
16. Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-29.
17. van Gameren II, Lokhorst H, Hazenberg BP, et al. Therapeutic options in systemic AL amyloidosis. Neth J Med 2004;62: 106-113.
18. Solomon A, Weiss DT, Wall JS. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies. Cancer Biother Radiopharm 2003;18:853-859.
19. Mihara M, Shiina M, Nishimoto N, et al. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis. J Rheumatol 2004;31:1132-1138.